PDSB
Pds Biotechnology Corp
$1.04+0.11 (11.83%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Edge Therapeutics, Inc. (EDGE) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 22 transactions (past 365 days)
| 2026-03-03 | 2026-01-12 | Bedu-Addo Frank | CEO | Award | 548,782 | $0.98 | $537,806 |
| 2026-03-03 | 2026-01-12 | Conn Gregory | CSO | Award | 150,000 | $0.98 | $147,000 |
| 2026-03-03 | 2026-01-12 | Boesgaard Lars | CFO | Award | 300,000 | $0.98 | $294,000 |
| 2026-03-03 | 2026-01-12 | Brown Spencer D. | VP | Award | 300,000 | $0.98 | $294,000 |
| 2026-03-03 | 2026-01-12 | Toutain Stephan | COO | Award | 300,000 | $0.98 | $294,000 |
| 2026-03-03 | 2026-01-12 | Freitag Gregory Gene | Director | Award | 54,876 | $0.98 | $53,778 |
| 2026-03-03 | 2026-01-12 | Iliev Ilian | Director | Award | 54,876 | $0.98 | $53,778 |
| 2026-03-03 | 2026-01-12 | Ali-Jackson Kamil | Director | Award | 54,876 | $0.98 | $53,778 |
| 2026-03-03 | 2026-01-12 | Brawley Otis W | Director | Award | 54,876 | $0.98 | $53,778 |
| 2026-03-03 | 2026-01-12 | Glover Stephen C. | Director | Award | 54,876 | $0.98 | $53,778 |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.